U.S. Wireless Telecom Stock News

Polaris (NYSE:PII) has launched an exclusive Slingshot Signature Edition, a limited-run model featuring major product changes and advanced technology. The new Signature Edition expands the Slingshot line with fresh design elements and upgraded in-cabin and performance-focused features. This release adds to Polaris' high-performance offerings in the powersports segment and targets riders seeking a more premium experience. Polaris, best known for its off-road vehicles, snowmobiles, and...

Mizuho recently upgraded Arthur J. Gallagher to “Outperform,” highlighting its reduced exposure to AI-driven disintermediation and its concentration on middle-market and large commercial clients, while the company also acquired German broker Krose GmbH & Co KG to expand its European operations and consulting capabilities. This combination of an analyst upgrade and a European acquisition underlines how Arthur J. Gallagher is leaning into higher-margin advisory and consulting services within...

AtaiBeckley (NasdaqGM:ATAI) reported FDA support to advance BPL-003, its proprietary intranasal formulation, into Phase 3 trials for treatment-resistant depression following an End-of-Phase 2 meeting. The company also released positive topline data from an exploratory Phase 2a study of EMP-01 in social anxiety disorder, indicating efficacy signals with a favorable safety profile. These updates reflect progress across two key programs in AtaiBeckley’s mental health pipeline that target...

Berkshire Hathaway, led by new CEO Greg Abel, has reduced its stake in Bank of America. The move is part of a broader rebalancing of Berkshire’s equity portfolio. This change affects one of NYSE:BAC’s largest long term shareholders and could influence how some investors view the stock. Bank of America, trading at $48.64 under ticker NYSE:BAC, is coming off a mixed stretch in the market. The stock is down 2.4% over the past week and 12.2% over the past month, and it shows a 13.1% decline...

Mueller Water Products, Inc. recently appointed long-time executive Scott Floyd as Executive Vice President and Chief Commercial Officer, formalizing his expanded commercial leadership across sales, marketing, and product lines built over nearly three decades at the company. This move consolidates commercial decision-making under an experienced insider at a time when the business is showing strong execution against analysts’ expectations and guidance. Next, we’ll examine how Mueller Water...

Pomerantz LLP has opened an investigation into Sunrun (NasdaqGS:RUN) over potential securities law violations and other unlawful business practices. The probe follows Sunrun's release of disappointing financial results and negative guidance for 2026. The investigation raises fresh legal and reputational questions for the residential solar provider at a time of heightened investor sensitivity. For investors watching Sunrun at $11.34, the new legal review comes after a sharp pullback, with...

If you are wondering whether C.H. Robinson Worldwide is still reasonably priced after its recent run, this article will walk through what the current share price might be implying about value. The stock last closed at US$179.64, with returns of 9.7% year to date and 78.7% over 1 year, although the share price has seen a 3.0% decline over 7 days and a 9.6% decline over 30 days. Recent coverage around C.H. Robinson Worldwide has focused on its role in global freight forwarding and logistics...

Recent share performance and business snapshot Deckers Outdoor (DECK) has drawn fresh attention after a weak week of trading, with the stock down about 11% over the past seven days and about 7% over the past month. For context, the company reports annual revenue of roughly US$5.37b and net income of about US$1.04b, supported by brands such as UGG and HOKA across retail, wholesale, and direct-to-consumer channels. See our latest analysis for Deckers Outdoor. Looking past the recent 11.1% 7 day...

Wondering if AptarGroup is priced attractively right now, or if the recent share moves have already baked in the value story you care about as an investor? The stock recently closed at US$132.08, with returns of 7.8% year to date, 2.2% over the last 30 days, an 8.1% decline over the last week, and a 12.4% decline over the past year, while the 3 year return sits at 21.9% and the 5 year return is flat. These mixed returns are landing at a time when investors are paying closer attention to how...

Cencora (NYSE:COR) held its annual shareholder meeting, confirming all board nominees. Shareholders approved the company's executive compensation plans. A new independent auditor was ratified to oversee Cencora's financial reporting. Management shared updated financial guidance and recent earnings results at the meeting. Cencora, a major player in pharmaceutical distribution and related services, sits at the core of how medicines move from manufacturers to healthcare providers. For...

Adeia Inc. has reported past fourth-quarter 2025 revenue of US$182.64 million and net income of US$73.71 million, alongside full-year 2025 revenue of US$443.39 million and net income of US$111.08 million, and has declared a quarterly dividend of US$0.0500 per share payable on March 30, 2026. The company has paired this earnings performance with ongoing capital returns, having completed a share repurchase of 12,884,000 shares since 2020 for US$212.27 million while continuing regular dividend...

In recent days, UnitedHealth Group filed an omnibus shelf registration to issue debt, preferred and common stock, and warrants, while its board confirmed a US$2.21 per-share cash dividend payable on March 17, 2026 to shareholders of record as of March 9, 2026. These moves come as the company works through its first revenue decline in a decade, losses in Optum Health, Medicare Advantage membership reductions and expanded Department of Justice scrutiny of its Medicare billing practices. We’ll...

Amer Sports (NYSE:AS) has completed a substantial follow-on equity offering. The transaction included several major financial institutions as co-lead underwriters, including BNP Paribas, UBS, Goldman Sachs, Citigroup, Evercore, and Morgan Stanley. The offering represents a material development for the company’s capital structure and financing plans. Amer Sports, known for its portfolio of sports and outdoor brands, operates at the intersection of performance gear, lifestyle, and...

Definium Therapeutics, Inc. reported full-year 2025 results on February 26, 2026, posting a net loss of US$183.79 million and a basic loss per share from continuing operations of US$2.06, both higher than the prior year. The widening loss highlights the financial strain of Definium’s development efforts even as it maintains visibility with investors through events like the TD Cowen Health Care Conference in Boston. We’ll now examine how this increased net loss shapes Definium Therapeutics’...

If you are wondering whether Marvell Technology at around US$89.57 still offers reasonable value, you are not alone, and the answer depends heavily on how you look at its valuation. The stock has seen sharp moves recently, with returns of 9.6% over the last 7 days, 20.7% over the last 30 days, 0.2% year to date, 26.9% over 1 year, 134.1% over 3 years and 93.8% over 5 years. These moves can change how the market prices its future potential and risk. Recent news flow has kept Marvell in focus,...

Marsh & McLennan Companies (NYSE:MRSH) has appointed Peter Harrison, former CEO of Schroders plc, to its Board of Directors. Harrison brings board and leadership experience from major global financial institutions and international business organizations. The appointment adds investment management and global governance expertise at a time of ongoing change in financial and risk markets. Marsh & McLennan sits at the intersection of risk, insurance brokerage, consulting, and...

NetScout Systems (NTCT) is back in focus after its 2025 second half DDoS Threat Intelligence Report flagged more complex, coordinated cyberattacks, while a recent analysis highlighted the company’s balance sheet strength and apparent value profile. See our latest analysis for NetScout Systems. Those DDoS report headlines and value-focused write ups come against a backdrop of steadily improving momentum, with a 90 day share price return of 10.78% and a 1 year total shareholder return of 39.06%...

Many investors are currently asking whether Baxter International's share price reflects its underlying value, as they watch how the stock is trading today. The shares last closed at US$17.69, after returns of a 13.2% decline over 7 days, a 15.9% decline over 30 days, a 9.3% decline year to date, and longer-term falls of 51.0% over 1 year, 50.2% over 3 years, and 74.8% over 5 years. Recent coverage on Baxter has focused on how the business is repositioning itself and responding to past...

In late February and early March 2026, Elevance Health disclosed that CMS plans to sanction its Medicare Advantage-Prescription Drug plans over alleged risk adjustment data issues, while also announcing leadership changes at Carelon and supporting a national diaper access pilot with the National Diaper Bank Network. The combination of potential CMS enrollment sanctions in a key Medicare Advantage segment and Elevance’s expanded community health initiatives raises important questions about...

Autodesk (ADSK) is back in focus after reporting fourth quarter and full year fiscal 2026 results that came in above the high end of its own guidance on revenue and margins, alongside a sizable restructuring toward AI and cloud. See our latest analysis for Autodesk. Autodesk’s share price is now US$260.99, with a 7 day share price return of 6.15% and a 30 day share price return of 7.22% after a softer 90 day patch. The 3 year total shareholder return of 34.52% suggests longer term holders...

nVent Electric (NVT) is back in focus after a wave of favorable analyst actions, including new coverage with a positive rating and several upgrades or reiterated upbeat recommendations from major brokerage firms. See our latest analysis for nVent Electric. That upbeat analyst sentiment comes after a sharp pullback in the share price, with a 1-day share price return showing a 4.10% decline and a 7-day share price return showing a 10.43% decline, even as the 1-year total shareholder return sits...

If you are wondering whether Zevra Therapeutics is attractively priced or already reflects its potential, the starting point is to understand how the current share price compares to a range of valuation measures. The stock closed at US$8.98, with returns of 0.6% over the last 7 days, 0.4% over 30 days, 7.7% year to date and 10.9% over 1 year. Over 3 years the return is very large at around 2x, while the 5 year return is a 4.4% decline. Recent news coverage around Zevra has focused on its...

Joby Aviation, Inc. reported fourth-quarter 2025 sales of US$30.84 million versus US$55,000 a year earlier, while reducing its quarterly net loss to US$121.54 million, and also announced a partnership with Uber to integrate its all‑electric air taxis into the Uber app for Dubai riders. The combination of rapidly growing early-stage revenue, a six-year exclusive air taxi agreement in Dubai, and app-based access via Uber highlights how Joby is beginning to commercialize its eVTOL ecosystem...

A national class of third party payors has been certified in a RICO lawsuit tied to alleged concealment of bladder cancer risk associated with diabetes drug Actos. The case targets Eli Lilly (NYSE:LLY) alongside Takeda and could expose the company to material legal, financial and reputational risk across a wide group of U.S. insurers and payors. Class certification expands potential claimant participation and may influence how future liabilities and settlement discussions develop. Eli...